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Strains of dengue 3 (DEN-3) virus circulating in Thailand prior to 1992 appear to have disappeared from that location and
to have been replaced by two new lineages which have evolved locally, rather than being introduced. Similar DEN-3 virus
extinctions may have occurred previously in Thailand in 1962 and 1973. Although no causal relationship could be shown, this
strain replacement event was accompanied by DEN-3 replacing DEN-2 as the serotype recovered most frequently from
patients in Thailand. Although this implies a change in selection pressure, we found no evidence for positive natural selection
at the level of either the E protein or the E protein gene. Further, the extinction of the pre-1992 strains and the appearance
of the new lineages occurred during an interepidemic period, suggesting that a genetic bottleneck, rather than selection,
might have been important in the emergence of these two new strains of virus. The pre-1992 DEN-3 virus lineage could still
be found in 1998, to the west, in Myanmar. The ratio of nonsynonymous-to-synonymous nucleotide changes within a DEN-3
virus population from a single patient was less than the ratio among the consensus sequences of DEN-3 viruses from
different patients, suggesting that many of the nonsynonymous nucleotide changes which occurred naturally in the E proteinINTRODUCTION
Human infection with dengue (DEN) viruses results in
a spectrum of symptoms ranging from inapparent to
haemorrhagic fever, hypovolemic shock, and death. It
has been estimated that three billion people between the
Tropics of Cancer and Capricorn are at risk of infection
with dengue viruses (Gubler, 1998) and that between
500,000 and 50,000,000 cases of clinical infection occur
annually (Gubler and Meltzer, 1999). There are four den-
gue virus serotypes (DEN-1 to DEN-4) and extensive
genetic variation exists in some genes within each se-
rotype. Phylogenetic analyses suggest that there are
regional foci of virus evolution and virgin soil dengue
outbreaks following introduction of viruses into suscep-
tible populations (Chungue et al., 1995; Hanna et al.,
2001; Lanciotti et al., 1974, 1977; Lewis et al., 1993;
Rico-Hesse, 1990; Rico-Hesse et al., 1997, 1998). There
are no dengue vaccines available, commercially, after
more than fifty years of research activity. However, atten-
uated vaccines are at various stages of development
(Bhamarapravati and Yoksan, 1997; Sardelis et al., 2000)
and there is an extensive literature relating to efforts to
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148develop dengue vaccines through recombinant DNA
technology (reviewed in Trent et al., 1997).
Although comparisons of consensus nucleotide se-
quences have provided some measure of genetic diver-
sity of dengue viruses sampled from different localities,
there have been fewer measures of genetic variation
between the consensus sequences of viruses from the
same location, recovered on a regular basis, over a
prolonged period. There has been no measure of genetic
variation within dengue virus populations from individual
hosts, particularly for DEN-3. Equally, it is unclear what
evolutionary processes shape the genetic diversity of
dengue viruses in nature, most notably whether the virus
responds to local ecological conditions and host im-
mune pressures by fixing adaptively favourable muta-
tions. Such analyses have been hindered by the chrono-
logical and geographical gaps in the virological record
from areas where dengue is endemic, due to the failure
to isolate dengue virus from patients and mosquitoes
routinely.
Determination of the evolutionary processes acting on
dengue viruses may have an impact on vaccination strat-
egies. For a vaccine to be effective in all geographical
locations, it must protect against infection with all den-
gue viruses. If virus populations in particular localities
are very diverse, there is a high likelihood that they will
be able to adapt rapidly to new ecological niches orwere deleterious and removed by purifying selection. © 2
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escape the host immune response and, perhaps, pro-002 Else
duce viruses with new phenotypic properties. One way to
examine this possibility is to study changes that are
occurring in dengue virus populations in areas where
there are high rates of infection and where the majority of
the human population becomes immune early in life; that
is, in localities where viruses are exposed to continuous
immunological pressure. Thailand is one such country.
Almost every year from 1973 until 1989, DEN-2 virus was
recovered most frequently from patients admitted to the
Queen Sirikit National Institute of Child Health (formally
the Bangkok Children’s Hospital) in Bangkok, Thailand.
Since 1995, DEN-3 has replaced DEN-2 as the most
frequently isolated virus and in the largest dengue epi-
demic in Thai history, in 1997–1998, DEN-3 was the most
frequently isolated dengue virus serotype (A. Nisalak,
unpublished observations).
Most epitopes involved in the serological neutralisa-
tion of dengue virus infection are located on the enve-
lope (E) protein (Roehrig, 1997). The E protein may also
contain determinants responsible for attachment of virus
to host cells and for fusion of virions with host cell
membranes (Crill and Roehrig, 2001). As such, it could be
the target of nonimmunological selective pressures as
the virus moves between nonimmune human hosts and
mosquito vectors or the target of immunological pres-
sure where hosts have preexisting antidengue virus an-
tibody.
This study addressed the questions of how much and
how quickly the E protein (gene) of dengue 3 viruses
changed in areas of high transmission and high herd
immunity. State-of-the-art techniques of evolutionary
analysis were used to reconstruct the molecular epide-
miological history of DEN-3 in Thailand and to determine
the selection pressures acting on the virus.
RESULTS
Consensus nucleotide sequences were derived for the
E protein gene of 21 DEN-3 viruses recovered from
patients in Thailand infected between 1987 and 1997—
two years in which large epidemics of dengue occurred,
and from one recent (1998) DEN-3 isolate from Myanmar
by sequencing cDNA derived by RT-PCR from viral RNA.
Excluding virus D88.303 (for reasons outlined below),
nucleotide variation occurred at 96 sites in the 1479
nucleotide E protein genes of these viruses with 13
changes resulting in amino acid changes. Only four of
the amino acid changes were nonconservative (E124
Ser-Pro, E132 Tyr-His, E404 Ala-Thr, E414 Gly-Glu). At 45
of these 96 sites, only one nucleotide differed from the
consensus sequence of all the isolates; at 28 sites, two
TABLE 1
Nucleotides at 18 Hypervariable Sites in the E Gene of Thai DEN-3 Viruses
Virus
Nucleotides at the positions indicated
952 982 1024 1030 1304 1328 1357 1447 1448 1459 1498 1543 1642 1966 2056 2197 2275 2370
D87.007 A G U C C C U U A A U A G U U U U C
D87.1384 A G U C U C U U A A U A G U U A U C
D87.561 A G U C U C U U A A U A G C U A U C
D88.086 A G U C U C U C A A U A G U U U U C
D89.273 A G U C U C U C A A C A G U U A U C
D91.538 A G U C C C U U A A G A G U U U U C
D91.393 A G U C C C U C A A U A G U U C U C
D92.431 A G U C C C U C A A U A G U U C U C
D92.423 A A U C C U C U G G C G A C C U C U
D93.044 A A U C C U C U G G C G A C C U C U
D93.674 G G C U C C C U A G U G A C C U C U
D94.283 A A C C C U C U G G C G A C C U C U
D94.122 G G C U C C C U A G U G A C C U C U
D95.0014 A A U C C U C U G G C G A C C U C U
D95.0400 G G C U C C C U A G U G G C C U C U
D96.330 A A U C C U C U G G C G A C C U C U
D96.313 G G C U C C C C A G U G A C C U C U
D97.0144 A A U C C U C U G G C G A C C U C U
D97.0106 G G C U C C C C A G U G A C C U C U
D97.0291 G G C U C C C U A G U G A C C U C U
Deduced amino acid changes
E124 E132 E172 E479
Pro His Ile Val
Ser Tyr Val Ala
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nucleotides differed from the consensus sequence and
at 5 sites, three nucleotides differed. Four or more nu-
cleotide changes occurred at each of 18 of the 96 sites
mentioned above (Table 1). Four of these sites contained
three different nucleotides. The 18 sites at which four or
more nucleotides varied from virus population consen-
sus sequence were not randomly distributed throughout
the E gene. Four were found between nucleotides 952
and 1030, six between nucleotides 1304 and 1459, and
three between nucleotides 1966 and 2197. The nucleo-
tide changes at 4 of these 18 sites results in amino acid
changes (E124 Ser-Pro, E132 Tyr-His, E172 Ile-Val, E479
Val-Ala).
To determine the extent of sequence diversity within the
DEN-3 consensus sequences, cDNA used for the determi-
nation of the nucleotide sequence of virus D92.431 was
cloned into pGEM-T vectors and used to transform Esche-
richia coli. The E protein gene inserts in plasmids from 20
colonies of transformed bacteria were sequenced. The
consensus sequence derived from the 20 clones was the
same as that derived by sequencing the cDNA used in the
cloning step. The E protein gene in plasmids from five
bacterial colonies had the same nucleotide sequence as
that derived from the original cDNA and the remainder
varied from the consensus sequence at 25 sites (Table 2).
The sequence of six clones varied from the consensus
nucleotide sequences at one site, five at two sites, three at
three sites, and one at four sites. The “variant” nucleotides
found at 8 of these 25 sites had been reported previously
for other DEN-3 viruses (Table 2). Twelve of the nucleotide
changes resulted in amino acid changes and one produced
a stop codon. The amino changes appeared to cluster in
a nonrandom manner, i.e., E74,85, E205,210,210,240,
E358,376,387, and E478,479. One of these cloned E protein
genes had nucleotides which varied from that of the con-
sensus sequence at positions 1764 (T-C, E277 Phe-Ser) and
2370 (C-T, E479 Ala-Val). The consensus sequence of all
Thai DEN-3 isolates recovered after 1992 had T at position
2370 in contrast to the C at this site in the pre-1992 samples
(see below).
To determine the evolutionary history of the Thai den-
gue viruses, the nucleotide sequence of their E protein
genes were compared with those from all previously
published E gene sequences of DEN-3 virus available in
GenBank (excluding putative recombinants; Worobey et
al., 1999). Phylogenetic analyses of these 50 nucleotide
sequences separated the viruses into five main groups,
which may be considered genotypes (Fig. 1). These ge-
notypes are similar to those identified by Lanciotti et al.
(1994), although our phylogenetic analysis shows that
genotype I of Lanciotti et al. (1994) encompasses two
distinct groups of viruses that we have classified sepa-
rately by constructing a new “genotype V.” As in previous
studies of DEN-3 diversity, the 1963 Puerto Rico strain
TABLE 2
Nucleotide and Deduced Amino Acid Variation between 20 E Protein Gene Clones from a Population of DEN-3 Virus (D92.431)
Position Nucleotide change Amino acid change Clone with this change Other examples from Genbank
1051 T-C 62 21, e.g., L11422a
1069 T-C 66 8, e.g., L11422
1090 A-G 65
1123 A-G 05, 09 7, e.g., L11424
1154 T-C E74 Cys-Arg 65
1171 A-G 05, 09, 42 2, e.g., L11433
1188 A-G E85 Glu-Gly 48
1444 A-G 48
1547 A-G E205 Met-Val 09
1563 G-A E210 Trp-Stop 10
1589 A-G E219 Thr-Ala 58
1652 A-G E240 Asn-Asp 65
1764 T-C E277 Phe-Ser 55
1801 A-G 66
1915 A-T 54
1924 T-C 42 2, e.g., L11423
2006 A-G E358 Lys-Glu 62
2062 A-G E376 Ile-Met 57
2094 T-C 37
2095 T-C E387 Ile-Thr 54 15, e.g., L11422
2221 A-G 62
2271 T-C E446 Phe-Ser 41
2314 C-T 09, 42 7, e.g., L11422
2367 T-C E478 Ile-Thr 38
2370 C-T E479 Ala-Val 55 12, e.g., L11422
a Genbank accession number.
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formed a distinct outlier. Differing numbers of amino acid
replacements have occurred on the lineages leading to
the five genotypes (Fig. 1). The distinct 1963 Puerto Rico
strain is separated from other DEN-3 viruses by 22 amino
acid changes dispersed across the E protein. In contrast,
genotype I is distinguished by four amino acid replace-
ments, genotype V by three such replacements, while
only a single change separates all members of genotype
III, although this also rises to five if the divergent
“Thail.62” strain is excluded. Finally, it is noticeable that
not a single amino acid change has occurred on the
lineage leading to genotype II.
FIG. 1.Maximum likelihood phylogenetic tree of E gene sequences from a global sample of 50 DEN-3 viruses. The genotypes are labelled according
to the scheme of Lanciotti et al. (1994), with genotype V newly identified here, and the amino acid changes distinguishing each group of viruses are
marked on the tree. The tree is mid-point rooted for purposes of clarity only and all horizontal branch lengths are drawn to scale. Bootstrap support
values are shown for key nodes only.
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The viruses sampled in this study fell into a number of
locations on the global phylogeny. Virus D88.303, iso-
lated in Thailand in 1988, clustered with viruses from
Indonesia, Malaysia, the Philippines, and the South Pa-
cific in genotype I. The remaining Thai isolates fell into
genotype II, therein clustering with a large group of
viruses including some previously sampled from Thai-
land as well as four viruses from Malaysia (strains
LN1746, LN2632, LN5547, LN6083; unpublished, direct
submission to GenBank). There also was an important
temporal division among the genotype II Thai viruses.
Specifically, strain D92.423 and all others sampled after
1992 form a phylogenetic group that is distinct (100%
bootstrap support) from all earlier isolates and a second
1992 strain, D92.431. Consequently, it appears that the
post-1992 strains have replaced the pre-1992 strains,
with isolate D92.423 the first representative of the new
viruses. A DEN-3 isolate made from a patient in Myan-
mar in 1998 (3198KLA) also clustered with the pre-1992
Thai viruses. Finally, the post-1992 groups of viruses can
be further subdivided into two cocirculating lineages
(designated “A” and “B” on Fig. 1), each with strong
bootstrap support.
The replacement of the pre-1992 viruses that occurred
in Thailand could have been due to natural selec-
tion—so that the later viruses had some phenotypic
characteristic that allowed them to out-compete the pre-
existing viruses—or be a chance occurrence, perhaps
caused by a population bottleneck. To choose between
these hypotheses, the selection pressures acting on
these sequences were examined in more detail. First,
the ratio of nonsynonymous (dN) to synonymous (d S)
changes (ratio dN/d S  ) was analysed using a recently
developed maximum likelihood approach which has
been found to provide a more accurate measure of se-
lective pressure than earlier pairwise methods (Yang and
Bielawski, 2000). Application of this method to the DEN-3
data provided a picture of relatively strong selective
constraints and no good evidence for positive selection.
Specifically, none of the models of codon evolution that
allow for positive selection were favoured over neutral
alternatives. Under the best supported model of codon
evolution (M3), the majority (83%) of nucleotide sites was
very highly constrained (dN/d S  0.0001), a smaller pro-
portion (15.6%) was moderately constrained (dN/d S 
0.261), and a single site, codon 380, fell into the ambig-
uous zone between neutral evolution and weak positive
selection (dN/d S  1.346). (Full results available from the
authors on request.) Furthermore, the branch leading to
the post-1992 Thai viruses is characterised by eight
nucleotide substitutions (nucleotide positions 1357, 1459,
1543, 1642, 1966, 2056, 2275, 2370), only one of which
resulted in the change of an amino acid (E479, A 3 V).
The possibility of selection acting at synonymous
codon positions was considered by examining patterns
of codon usage bias and RNA secondary structure.
Codon usage by the pre-1992 viruses and the two more
recent groups of Thai DEN-3 viruses were similar so it is
unlikely that this represents a selected difference be-
tween them (results not shown, available on request).
The possibility of selection acting on RNA secondary
structure stems from the apparently nonrandom distribu-
tion of the 16 hypervariable sites. The free energy of
predicted RNA secondary structures in the three regions
of the E gene where hypervariable sites clustered were
compared using representative members of each of
three groups of Thai DEN-3 viruses—pre-1992, and the
two lineages of post-1992 viruses. Viruses selected var-
ied only at one or more of the hypervariable sites in the
region under study. The free energy of the predicted RNA
secondary structure of the first region (nucleotides 935–
1175) varied from 51.4 to 54.4 kcal/mol between the
three groups, that of the second region (nucleotides
1356–1575) from 37.5 to 42.4 kcal/mol, and for the
third region (nucleotides 2115–2401) from 46.7 to 48.2
kcal/mol. Hence, there is little evidence that the post-
1992 Thai viruses gained a selective advantage through
changes in RNA secondary structure. Finally, no evi-
dence was found that the post-1992 viruses had arisen
by recombination between DEN-3 viruses circulating be-
fore that date in either Thailand or elsewhere, as there
was no evidence strains moved position across the tree
as expected under recombination.
DISCUSSION
The data presented here suggest that strains of DEN-3
virus circulating in Thailand up to 1992 have disappeared
from that country but are still circulating in at least one
neighbouring locality (Myanmar, represented by strain
31985KLA sampled in 1998). Since 1992, two new lin-
eages of DEN-3 viruses have appeared from a single
common ancestor and are cocirculating. There also ap-
peared to have been an incursion into Thailand by an
“Indonesian/Malaysian-like” strain of DEN-3 in 1988 (rep-
resented by strain D88.303) but this failed to become
established as none of the later Thai samples grouped
with this isolate. It is unclear whether this was due to
competition with more fit strains of DEN-3 virus circulat-
ing in Thailand, to regional differences in mosquito vec-
tor competence for each of these viruses (Gubler et al.,
1979), or because the scope of the virus sampling was
too limited to detect “rare” populations of virus. Finally,
the distinct temporal nature of the DEN-3 phylogeny—
with progressively more recent viruses tending to fall
toward the tips of the tree—suggests that there might be
regular extinctions of strains of DEN-3 virus in Thailand
(e.g., the 1962, 1973, and the 1986–1992 strains) and in
other localities.
More difficult to discern are the evolutionary causes of
the extinctions and replacements documented, in partic-
ular, whether they are due to underlying differences in
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fitness or to the vagaries of population bottlenecks. It is
intriguing that by 1993 the pre-1992 strains of DEN-3
disappeared from the sites studied in this project, and by
1995 (2–3 years after the putative genetic bottleneck)
DEN-3 had become the most frequently isolated dengue
virus serotype in Thailand (A. Nisalak, personal commu-
nication). This suggests that the strain replacement we
document was associated with the emergence of DEN-3
as the dominant dengue serotype, compatible with a
selectively driven event. However, other than on the
branch leading to the Puerto Rico 1963 strain, the E gene
of DEN-3 is relatively conserved at the amino acid level.
However, four amino acid changes occurred more fre-
quently within the genotype II Thai strains—E124 S-P,
E132 H-Y, E172 I-V, E479 V-A (Table 1). Those at E124
(S-P) and E132 (H-Y) were nonconservative and there are
several reports of amino acid changes in the E protein of
dengue viruses in the vicinity of amino acids E124 and
E132 that influence neurovirulence for mice (possibly as
a result of changes in cell trophism; Bray et al., 1998;
Gualano et al., 1998) and cell fusion (Guirakhoo et al.,
1993) and this region contains significant linear and,
possibly, conformational serological epitopes (Aaskov et
al., 1989; Innis et al., 1989; Lok et al., 2001). There also is
evidence of linear and conformational epitopes in the
region E160–172 of dengue viruses (Aaskov et al., 1989;
Serafin and Aaskov, 2001), where one of the conservative
amino acid changes in the DEN-3 virus E protein was
observed (E172 I-V). It is more difficult to identify a se-
lective advantage associated with a conservative amino
acid change in the second, putative, transmembrane
region of the DEN-3 E protein (E479 A-V), although this is
the only amino acid difference between the pre- and
post-1992 viruses. The change to a more hydrophobic
amino acid (V) might aid insertion, or retention, of this
region in the lipid envelope of the virion or alternatively it
might influence the efficiency of the posttranslational
cleavage of E-NS1. These changes were all quite distinct
from the E390, domain III, amino acid changes that has
been suggested to influence virulence of DEN-2 virus in
humans (Leitmeyer et al., 1999) and which was also
found to be associated with variation in neurovirulence
of DEN-2 virus in mice (Sanchez and Ruiz, 1996).
Despite these putative functional differences, statisti-
cal analyses of the selection pressures acting on amino
acid sites in the E gene provided no compelling evidence
for adaptive evolution (positive selection) on those lin-
eages where strain replacement was most apparent.
Although this rules out natural selection on the envelope
glycoprotein as the underlying cause of strain replace-
ment, it is possible that adaptively useful mutations have
been fixed in other genes or noncoding regions, but this
could only be resolved with sequencing the complete
genome. Furthermore, it is possible that natural selection
was acting on RNA secondary structure or on codon
usage. There is at least one example of the tissue-
specific availability of t-RNA influencing the replicative
capacity of a virus (Zhou et al., 1999), although this has
not been documented in RNA viruses. However, there
was no evidence of a change in codon usage with
evolution of the Thai DEN-3 strains. Also, while accept-
ing the limitations of RNA secondary structure prediction
programs such as MFold (Zuker, 1989), there was no
evidence that regions of the E protein gene undergoing
evolutionary change in these viruses were evolving to
more stable forms of RNA secondary structure.
On the other hand, there are good reasons why sto-
chastic processes may have a major effect on the ge-
netic diversity of DEN-3 virus in Thailand. Mosquito
transmission of virus to a human host requires as little as
1–3 l of infectious saliva, providing an ideal opportunity
for a genetic bottleneck in a virus population. On the
other hand, both theoretical and laboratory studies sug-
gest that a genetic bottleneck is most likely to give rise
to a virus population that is less fit than the one from
which it was derived (Escarmis et al., 1996; Novella et al.,
1999). Furthermore, 1992 was an interepidemic year
when the number of dengue cases in Thailand was
relatively low, suggesting that virus transmission would
also have been low (41,125 cases in 1992 compared with
174,285 in 1987 and 101,689 in 1997; A. Nisalak, unpub-
lished observations). In contrast, in Myanmar, where the
pre-1992 DEN-3 genotype was still circulating in 1998,
DEN-1, 2, and 3 viruses were being recovered from pa-
tients in approximately similar numbers (H. M. Thu, un-
published observations). Moreover, there is a previous
report suggesting that a genetic bottleneck occurred
between 1980 and 1987 in Thailand, which may have
been responsible for a change in DEN-2 virus popula-
tions over that time interval (Sittisombut et al., 1997). In
this study, which covered similar areas over an equiva-
lent time interval, DEN-2 populations were found to be
stable and homogeneous (Rico-Hesse et al., 1998) at a
time when DEN-3 viruses were undergoing rapid
change.
Finally, the variation between the nucleotide sequences
of 20 E protein genes within a single virus population
represented by a single consensus sequence (D92.431)
was, as expected, significantly less than the variation seen
between different virus consensus sequences. Further-
more, the number of synonymous (12) and nonsynonymous
(13) nucleotide changes within a single DEN-3 virus con-
sensus sequence was almost equal (Table 2), whereas
between different viral consensus sequences, the number
of synonymous changes greatly exceeded the number of
nonsynonymous changes 83:13. This difference in dN/dS
ratios indicates that the E gene sequences contained
within a single consensus sequence are a measure of the
total mutant spectrum, which would predict more even
numbers of synonymous and nonsynonymous changes,
and that many of the nonsynonymous changes are delete-
rious and are subsequently removed by purifying selection.
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The virus containing a genome with a stop codon (Table 2,
clone 10, nt 1563) is unlikely to be viable and may represent
a defective interfering particle. While it is possible that
some of the changes observed could have been due to
errors introduced by Taq polymerase and not removed by
Pwo during PCR, the error rate should have been the same
for the cDNA used to produce the clones and for the cDNA
used to determine the nucleotide sequences of the viral
genome and so might not be expected to alter these con-
clusions.
In sum, this study provides an example of how quickly
dengue virus gene sequences, and perhaps phenotypes,
can change in local populations. It also is salutary to
observe, in a region where all for dengue serotypes are
circulating, that rapid change can occur in one serotype
at times of relative stasis in a second and serves to
highlight, yet again, the differences between the disease
patterns of each of the dengue virus serotypes (Vaughn
et al., 2000).
MATERIALS AND METHODS
Virus
Viruses, their origins, and passage histories are
shown in Table 3. Most Thai viruses were isolated in
Toxorhynchites splendens mosquitoes. All viruses were
passaged at least once in C6-36 Aedes albopictus mos-
quito cells before sequencing.
Nucleotide sequencing
Nucleotides have been numbered from the 5 end of
the DEN-3 genome according to the scheme of Osatomi
and Sumiyoshi (1990). Deduced amino acid sequences
have been numbered from the amino-terminal of the E
protein.
RNA was recovered, using viral RNA extraction col-
umns (Qiagen, Australia) according to the manufacturer’s
instructions, from virus in supernatant from cultures of
C6-36 cells infected 7 days previously. The RNA was
transcribed to cDNA using random hexamer oligonucle-
otides (Roche, Germany) and avian myeloblastosis virus
(AMV) reverse transcriptase (Roche) and incubations of
55°C for 10 min followed by 45°C for 60 min. The cDNA
was amplified using sense (P722) and antisense (CP
2550) oligonucleotide primers (Lanciotti et al., 1994) and
“Expand polymerase” (a mixture of Taq and Pwo poly-
merases; Roche) with cycling times as follows
94°C 2 min 1 cycle
94°C 30 s
45°C 30 s 35 cycles
68°C 90 s
68°C 5 min 1 cycle
The PCR product was analysed on 1.5% w/v agarose/
Tris acetate–EDTA (TAE) gels and the cDNA band of
interest excised and purified using silica “glass milk”
according to the manufacturer’s instructions (Bresatech,
Australia).
This cDNA was sequenced (see below) or in the case
of some cDNA from virus D92.431, “tailed” with ATP to
allow cloning into pGEM-T plasmids (Promega). Briefly,
the cDNA was incubated with 0.1 mol dATP and 1 U Taq
polymerase (Perkin Elmer) for 1 h at 72°C to add ATP at
the 3 end of each strand of DNA and then purified using
a High Pure PCR Product Purification Kit (Roche). Eight
microliters of the A-cDNA was ligated into 50 ng plasmid
by incubating the mixture at 4°C overnight in the pres-
ence of T4 ligase (Promega). Competent E. coli (DH5
alpha; Life Technologies, Australia) were transformed
with 4 l of the ligation mix and then plated on Lauria–
Bertani agar supplemented with 50 g/ml ampicillin, 0.5
mM ispropyl--D-thiogalactopyranoside, and 80 g/ml
TABLE 3
Patients, Location, and Passage History of DEN-3 Viruses Used in this Study
Virusa Diseaseb Infection Passagec Location Virus Disease Infection Passage Location
D87.007 DF Primary Ts-1, C6-36-4 Bangkok D93.674 DF Secondary Ts-1, C6-36-2 Bangkok
D87.1384 DHF III Secondary Ts-1, C6-36-2 Bangkok D94.122 DHF III Secondary Ts-1, C6-36-2 Surin
D87.561 DHF II Secondary Ts-1, C6-36-2 Patumthani D94.283 DHF II Secondary Ts-1, C6-36-2 Samutprakan
D88.086 DHF III Secondary Ts-1, C6-36-2 Bangkok D95.0014 DHF II Primary Ts-1, C6-36-2 Samutprakan
D88.303 DHF III Secondary Ts-1, C6-36-2 Patumthani D95.0400 DHF III Primary Ts-1, C6-36-2 Bangkok
D89.273 DHF III Secondary Ts-1, C6-36-2 Bangkok D96.313 DF Primary Ts-1, C6-36-2 Bangkok
D91.393 DHF I Primary Ts-1, C6-36-2 Bangkok D96.330 DHF II Secondary C6-36-4 Surin
D91.538 DHF II Secondary Ts-1, C6-36-3 Bangkok D97.0106 DHF III Secondary C6-36-4 Pratumthani
D92.423 DHF II Secondary Ts-1, C6-36-2 Bangkok D97.0144 DHF II Secondary C6-36-4 Bangkok
D92.431 DF Primary Ts-1, C6-36-2 Bangkok D97.0291 Unknown Secondary C6-36-4 Samutpraken
D93.044 DHF II Primary Ts-1, C6-36-2 Nonthaburi 31985KLA DHF II Secondary C6-36-1 Yangon,
Myanmar
a The first two numerals indicate the year of isolation and those after the point, the sample number. Sample 31985KLA was isolated in 1998.
b DF, dengue fever; DHF, dengue haemorrhagic fever (I, II, II grade I, II, or III).
c Ts1, passaged once in T. splendens mosquitoes. C6-36 -2, 3, 4, passaged 2, 3, or 4 times in C6-36 mosquito cells.
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5-bromo-4-chloro-3-indoyl--D-galactopyranoside and in-
cubated at 37°C for 24 h. Discrete white colonies from
the plates were inoculated into 2 ml SOC broth and
incubated for 24 h at 37°C with shaking at 225 rpm.
Plasmids were recovered from each broth culture using
a Plasmid Purification Kit according to the manufactur-
er’s instructions (Qiagen).
cDNA and plasmid inserts were sequenced using the
ABI PRISM Dye Terminator Cycle Sequencing Ready
Reaction Kit (Perkin Elmer) according to the manufactur-
er’s instructions and the products were anlaysed on an
Applied Biosystems Nucleotide Sequencer. The oligonu-
cleotide primers of Lanciotti et al. (1994) were used to
sequence both strands of the ds-cDNA. Where sequence
ambiguity was detected, cDNA was resequenced or
fresh cDNA prepared and sequenced.
Nucleotide sequences were aligned; codon usage
was quantitated, and RNA secondary structure predic-
tions were performed with software (ClustalW, codonfre-
quency, Mfold, respectively) available online from the
Australian National Genomic Information Service (www.
angis.org.au).
Evolutionary analysis
The nucleotide sequences generated in this study
were combined with those of all other DEN-3 E protein
gene sequences available on GenBank (Table 4), exclud-
ing those previously shown to have evidence of recom-
bination (Worobey et al., 1999). This resulted in a total
data set of 50 sequences.
Phylogenetic trees were estimated using the maxi-
mum likelihood (ML) method available in the PAUP*
phylogeny reconstruction package (Swofford, 2000). The
general time-reversible (GTR) model of nucleotide sub-
stitution was employed, with the rate of each substitution
(A-C, A-G, etc.), the base frequencies, and the rates of
nucleotide substitution at each codon position that gave
the highest likelihood estimated from the data. Parame-
ter values are available from the authors on request.
Successive rounds of branch-swapping were used to
find the most likely tree under this model. The robust-
ness of each node on the tree was assessed using the
bootstrap resampling method, with all 1000 replicates
estimated using the neighbor-joining procedure, but with
the input genetic distances produced under the ML sub-
stitution model.
The ML method of Yang et al. (2000) (implemented in
the PAML package; Yang, 1997) was used to examine
selection pressures in DEN-3. This approach is based on
an analysis of the numbers of nonsynonymous (dN) and
synonymous (d S) substitutions per site for each codon,
using various models of codon evolution. The model with
the highest likelihood best explains the data. If this
model shows dN/d S  1, then the predominant evolution-
ary process is purifying selection, whereas dN/d S  1
reflects neutral evolution and dN/d S  1 indicates posi-
tive selection. Bayesian methods can also be used to
calculate the probability that a particular codon falls into
a specific site class, such as those thought to be posi-
tively selected. The simplest codon model, M0, estimates
a single dN/d S for all sites. In contrast, M1 can be thought
of as a neutral model as it divides codons into two
categories, one for those sites that are invariant (dN/d S
0), and second category, representing neutral codon
sites, where dN/d S  1. M2 can account for positive
selection because a third category of codons is incorpo-
rated at which dN/d S (estimated from the data) can be
1. In M3, the dN/d S ratio is estimated from the data for
three site classes whose size is also determined from
the data. This model also allows for positive selection
because the dN/d S for any codon class can be 1. Both
M7 and M8 use a discrete beta distribution (with 10
categories) to model dN/d S ratios among codons but M8
differs from M7 in that it estimates an 11th category of
codon sites at which dN/d S can be 1. Because some
models are nested within each other—both M0 and M1
TABLE 4
DEN 3 Virus Nucleotide Sequences from GenBank Used in
Phylogenetic Analyses
Virus
GenBank accession
number Comment*
Fiji.92 L11422 Fiji, 1992
India.84 L11424 India, 1984
Indon.73 L11425 Indonesia, 1973
Indon.78 L11426 Indonesia, 1978
Indon.85 L11428 Indonesia, 1985
Malay.74 L11429 Malaysia, 1974
Malay.81 L11427 Malaysia, 1981a
Philip.56 L11423 Philippines, 1956
Philip.83 L11432 Philippines, 1983
PRico.63 L11433 Puerto Rico, 1963
Samoa.86 L11435 Samoa, 1986a
SLanka.81 L11431 Sri Lanka, 1981
SLanka.85 L11436 Sri Lanka, 1985
SLanka.89 L11437 Sri Lanka, 1989
SLanka.91 L11438 Sri Lanka, 1991
Tahiti.89 L11619 Tahiti, 1989
Thail.62 L11440 Thailand, 1962
Thail.73 L11620 Thailand, 1973
Thail.86 L11441 Thailand, 1986
Thail.87 L11442 Thailand, 1987
Brazil2000 AY038605 Brazil, 2000a
CH53489 M86733 Thailand, 1973a
PaH881/88 AF349753 Thailand, 1988a
80-2 AF317645 China, 1980
LN1746 AF147458 Malaysia, 1993
LN2632 AF147459 Malaysia, 1993
LN5547 AF147457 Malaysia, 1992
LN6083 AF147460 Malaysia, 1994
a There is no information about the sources of these viruses accom-
panying their GenBank entry. All other viruses in the table were recov-
ered from humans.
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are nested with M2 and M3, and M7 is nested with
M8—these can be compared directly using standard
likelihood ratio test statistics.
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